IL1B and brain neoplasm: Data also suggested that the neural stem cell–like GBM stem cell (GSC), also known as brain tumor-initiating cell (BTIC), fraction that is associated with therapeutic resistance may be enriched with knockout of Il1a and Il1b compared with loss of Il1b alone (8).